SWOG clinical trial number
SWOG-8640
Evaluation of Didemnin-B or Trimetrexate in the Treatment of Metastatic or Recurrent Squamous Carcinoma of the Uterine Cervix
Closed
Phase
Accrual
88%
Published
Abbreviated Title
Evaluation of Didemnin-B or Trimetrexate in the Treatment of Metastatic or Recurrent Squamous Carcinoma of the Uterine Cervix
Activated
10/01/1987
Closed
07/15/1990
Publication Information Expand/Collapse
1992
A randomized phase II trial of trimetrexate or didemnin B for the treatment of metastatic or recurrent squamous carcinoma of the uterine cervix: A Southwest Oncology Group trial.